McTigue; Michele Ann

Patent Applications and Registrations

Patent applications and USPTO patent grants for McTigue; Michele Ann.The latest application filed is for "azalactam compounds as hpk1 inhibitors".

Company Profile

4.6.8

McTigue; Michele Ann - Encinitas CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Azalactam compounds as HPK1 inhibitors Grant 11,142,525 - Gallego , et al. October 12, 2	2021-10-12
Substituted carbonucleoside derivatives useful as anticancer agents Grant 10,709,709 - Tatlock , et al.	2020-07-14
Azalactam Compounds as HPK1 Inhibitors App 20200172539 - Gallego; Rebecca Anne ; et al.	2020-06-04
Substituted nucleoside derivatives useful as anticancer agents Grant 10,428,104 - Tatlock , et al. October 1, 2	2019-10-01
Substituted Carbonucleoside Derivatives Useful As Anticancer Agents App 20190111060 - Tatlock; John Howard ; et al.	2019-04-18
Substituted carbonucleoside derivatives useful as anticancer agents Grant 10,220,037 - Tatlock , et al.	2019-03-05
Substituted Carbonucleoside Derivatives Useful As Anticancer Agents App 20170348313 - Tatlock; John Howard ; et al.	2017-12-07
Substituted Nucleoside Derivatives Useful As Anticancer Agents App 20160244475 - Tatlock; John Howard ; et al.	2016-08-25
Macrocyclic derivatives for the treatment of diseases Grant 9,133,215 - Bailey , et al. September 15, 2	2015-09-15
Macrocyclic Derivatives For The Treatment Of Diseases App 20140135339 - Bailey; Simon ; et al.	2014-05-15
Macrocyclic derivatives for the treatment of diseases Grant 8,680,111 - Bailey , et al. March 25, 2	2014-03-25
Macrocyclic Derivatives For The Treatment Of Diseases App 20130252961 - BAILEY; Simon ; et al.	2013-09-26
Crystal structure of VEGFRKD: ligand complexes and methods of use thereof App 20050197492 - Bender, Steven Lee ; et al.	2005-09-08
Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof App 20040009568 - Mroczkowski, Barbara ; et al.	2004-01-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.